Background and aim: Clinical, genetic and experimental evidence indicates that proprotein convertase subtilisin/kexin 9 (PCSK9) may be either a cause or an effect of metabolic syndrome (MetS). We have recently demonstrated that PCSK9 is regulated by pro-inflammatory cytokine TNF-α in a SOCS3-dependent manner (Ruscica et al., JBC, 2016). Thus, the present work aimed to further extend this observation and studied the possible molecular mechanisms linking the effects of cytokines (TNF-α) and adipokines (leptin and resistin) on de novo lipogenesis and PCSK9 expression. Methods: Human hepatocellular liver carcinoma cell line (HepG2) and HepG2 overexpressing PCSK9 (HepG2_PCSK9) were used as in vitro tools. qPCR, Western blot, ELISA and luciferase reporter assays, together with siRNA directed to STAT3 and SOCS3, were used. Results: HepG2 cells express leptin (ObRb) and resistin (Adenylyl cyclase-associated protein 1, CAP1) receptors; the overexpression of PCSK9 in HepG2 (HepG2_PCSK9) does not alter that of ObRl and CAP-1. Fourty-eight-h treatment of HepG2 with TNF-α (10 ng/mL), leptin (200 ng/mL) and resistin (50 ng/mL) induced the expression of both PCSK9 (2.3-, 2.0- and 3.5-fold, respectively) and JAK/STAT pathway (3-, 1.8- and 1.9-fold, respectively). TNF-α and leptin increased the amount of secreted PCSK9 by 15%. Only leptin stimulated PCSK9 promoter activity after 24- and 48-h treatment (+52 and +26%, respectively). TNF-α, leptin and resistin induced the gene expression of apoB, sterol regulatory element-binding protein 1 (SREBP1), stearoyl-CoA desaturase-1 (SCD-1), fatty acid synthase (FAS) and microsomal triglyceride transfer protein (MTP). These effects, along with the activation of PCSK9, were inhibited by transfection with siRNA anti-STAT3, suggesting the involvement of the JAK/STAT pathway. Conclusions: Pro-inflammatory cytokines and adipokines up-regulate PCSK9 expression and the key genes involved in the de novo lipogenesis. Future analyses will investigate the potential role of JAK/STAT pathways in mediating these effects.

Pro-inflammatory cytokines and adipokines regulate PCSK9 expression in HepG2 cells / M. Ruscica, M. Botta, M. Garzone, C. Macchi, S. Marchiano, A. Corsini, P. Magni, N. Ferri. - In: NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. - ISSN 0939-4753. - 27:1(2017 Jan), pp. e35-e35. ((Intervento presentato al 30. convegno Società Italiana per lo Studio dell'Aterosclerosi tenutosi a Roma nel 2016 [10.1016/j.numecd.2016.11.097].

Pro-inflammatory cytokines and adipokines regulate PCSK9 expression in HepG2 cells

M. Ruscica
Primo
;
M. Botta
Secondo
;
C. Macchi;S. Marchiano;A. Corsini;P. Magni
Penultimo
;
N. Ferri
Ultimo
2017

Abstract

Background and aim: Clinical, genetic and experimental evidence indicates that proprotein convertase subtilisin/kexin 9 (PCSK9) may be either a cause or an effect of metabolic syndrome (MetS). We have recently demonstrated that PCSK9 is regulated by pro-inflammatory cytokine TNF-α in a SOCS3-dependent manner (Ruscica et al., JBC, 2016). Thus, the present work aimed to further extend this observation and studied the possible molecular mechanisms linking the effects of cytokines (TNF-α) and adipokines (leptin and resistin) on de novo lipogenesis and PCSK9 expression. Methods: Human hepatocellular liver carcinoma cell line (HepG2) and HepG2 overexpressing PCSK9 (HepG2_PCSK9) were used as in vitro tools. qPCR, Western blot, ELISA and luciferase reporter assays, together with siRNA directed to STAT3 and SOCS3, were used. Results: HepG2 cells express leptin (ObRb) and resistin (Adenylyl cyclase-associated protein 1, CAP1) receptors; the overexpression of PCSK9 in HepG2 (HepG2_PCSK9) does not alter that of ObRl and CAP-1. Fourty-eight-h treatment of HepG2 with TNF-α (10 ng/mL), leptin (200 ng/mL) and resistin (50 ng/mL) induced the expression of both PCSK9 (2.3-, 2.0- and 3.5-fold, respectively) and JAK/STAT pathway (3-, 1.8- and 1.9-fold, respectively). TNF-α and leptin increased the amount of secreted PCSK9 by 15%. Only leptin stimulated PCSK9 promoter activity after 24- and 48-h treatment (+52 and +26%, respectively). TNF-α, leptin and resistin induced the gene expression of apoB, sterol regulatory element-binding protein 1 (SREBP1), stearoyl-CoA desaturase-1 (SCD-1), fatty acid synthase (FAS) and microsomal triglyceride transfer protein (MTP). These effects, along with the activation of PCSK9, were inhibited by transfection with siRNA anti-STAT3, suggesting the involvement of the JAK/STAT pathway. Conclusions: Pro-inflammatory cytokines and adipokines up-regulate PCSK9 expression and the key genes involved in the de novo lipogenesis. Future analyses will investigate the potential role of JAK/STAT pathways in mediating these effects.
Settore BIO/14 - Farmacologia
Settore MED/04 - Patologia Generale
Settore MED/05 - Patologia Clinica
Article (author)
File in questo prodotto:
File Dimensione Formato  
PIIS0939475316302897.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 40.11 kB
Formato Adobe PDF
40.11 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/467747
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact